Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Placebo-Controlled, Single-Blind, Dose Range-Finding Study of Inhaled ALX1 in Adults With Bronchiectasis

NCT07731919 is registered in ClinicalTrials.gov with Vast Therapeutics as lead sponsor.

NCT NCT07731919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Placebo-Controlled, Single-Blind, Dose Range-Finding Study of Inhaled ALX1 in Adults With Bronchiectasis
Lead sponsor
Vast Therapeutics
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 31, 2027
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis adult